Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 433-446 , June 2008

Single gene mutations causing SGA

References 

  1. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews. 1998;19:717–797
  2. Le Roith D, Bondy C, Yakar S, et al. The somatomedin hypothesis: 2001. Endocrine Reviews. 2001;22:53–74
  3. Dupont J, Holzenberger M. Biology of insulin-like growth factors in development. Birth Defects Research. Part C, Embryo Today. 2003;69:257–271
  4. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Reviews. 1989;10:68–91
  5. Boisclair YR, Rhoads RP, Ueki I, et al. The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. The Journal of Endocrinology. 2001;170:63–70
  6. Adams TE, Epa VC, Garrett TP, et al. Structure and function of the type 1 insulin-like growth factor receptor. Cellular and Molecular Life Sciences. 2000;57:1050–1093
  7. LeRoith D, Werner H, Beitner-Johnson D, et al. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Reviews. 1995;16:143–163
  8. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003;24:803–812
  9. Scavo LM, Serrano J, Roth J, et al. Genes for the insulin receptor and the insulin-like growth factor I receptor are expressed in the chicken embryo blastoderm and throughout organogenesis. Biochemical and Biophysical Research. 1991;176:1393–1401
  10. Schultz GA, Hahnel A, Arcellana-Panlilio M, et al. Expression of IGF ligand and receptor genes during preimplantation mammalian development. Molecular Reproduction and Development. 1993;35:414–420
  11. Lighten AD, Hardy K, Winston RM, et al. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos. Molecular Reproduction and Development. 1997;47:134–139
  12. Kim S, Lee SH, Kim JH, et al. Anti-apoptotic effect of insulin-like growth factor (IGF)-I and its receptor in porcine preimplantation embryos derived from in vitro fertilization and somatic cell nuclear transfer. Molecular Reproduction and Development. 2006;73:1523–1530
  13. Spanos S, Becker DL, Winston RML, et al. Anti-apoptotic action of insulin-like growth factor-I during human preimplantation embryo development. Biology of Reproduction. 2000;63:1413–1420
  14. Efstratiadis A. Genetics of mouse growth. International Journal of Developmental Biology. 1998;42:955–976
  15. Salvatori R, Fan X, Veldhuis JD, et al. Serum GH response to pharmacological stimuli and physical exercise in two siblings with two new inactivating mutations in the GH-releasing hormone receptor gene. European Journal of Endocrinology. 2002;147:591–596
  16. Fluck C, Deladoey J, Rutishauser K, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg→Cys at codon 120 (R120C). The Journal of Clinical Endocrinology and Metabolism. 1998;83:3727–3734
  17. Hess O, Hujeirat Y, Wajnrajch MP, et al. Variable phenotypes in familial isolated growth hormone deficiency caused by a G6664A mutation in the GH-1 gene. The Journal of Clinical Endocrinology and Metabolism. 2007;92:4387–4393
  18. Wit JM, van Unen H. Growth of infants with neonatal growth hormone deficiency. Archives of Disease in Childhood. 1992;67:920–924
  19. Rosenfeld RG, Belgorosky A, Camacho-Hubner C, et al. Defects in growth hormone receptor signaling. Trends in Endocrinology and Metabolism. 2007;18:134–141
  20. Savage MO, Blum WF, Ranke MB, et al. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). The Journal of Clinical Endocrinology and Metabolism. 1993;77:1465–1471
  21. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. The Journal of Clinical Endocrinology and Metabolism. 2004;89:1031–1044
  22. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, et al. Growth hormone receptor deficiency in Ecuador. The Journal of Clinical Endocrinology and Metabolism. 1999;84:4436–4443
  23. Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75:59–72
  24. Baker J, Liu JP, Robertson EJ, et al. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73–82
  25. Woods KA, Camacho-Hubner C, Savage MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. The New England Journal of Medicine. 1996;335:1363–1367
  26. van Gemund JJ. Laurent de Angulo MS & van Gelderen HH. Familial prenatal dwarfism with elevated serum immuno-reactive growth hormone levels and end-organ unresponsiveness. Maandschrift voor Kindergeneeskunde. 1969;37:372–382
  27. Walenkamp MJ, Karperien M, Pereira AM, et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. The Journal of Clinical Endocrinology and Metabolism. 2005;90:2855–2864
  28. Denley A, Wang CC, McNeil KA, et al. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Molecular Endocrinology. 2005;19:711–721
  29. Bonapace G, Concolino D, Formicola S, et al. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. Journal of Medical Genetics. 2003;40:913–917
  30. Coutinho DC, Coletta RR, Costa EM, et al. Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre and postnatal growth impairment. The Journal of Clinical Endocrinology and Metabolism. 2007;92:4889–4892[Epub ahead of print]
  31. Netchine I, Azzi S, Houang M, et al. Partial IGF-I deficiency demonstrates the critical role of IGF-I in growth and brain development. Hormone Research. 2006;65(Suppl. 4):29
  32. Murphy VE, Smith R, Giles WB, et al. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocrine Reviews. 2006;27:141–169
  33. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). The Journal of Clinical Endocrinology and Metabolism. 2002;87:2720
  34. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002;359:1036–1037
  35. Powell-Braxton L, Hollingshead P, Warburton C, et al. IGF-I is required for normal embryonic growth in mice. Genes & Development. 1993;7:2609–2617
  36. Russo VC, Gluckman PD, Feldman EL, et al. The insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews. 2005;26:916–943
  37. D'Ercole AJ, Ye P, O'Kusky JR. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides. 2002;36:209–220
  38. McDonald TJ, Nijland MJ, Nathanielsz PW. The insulin-like growth factor system and the fetal brain: effects of poor maternal nutrition. Reviews in Endocrine & Metabolic Disorders. 2007;8:71–84
  39. Kranzler JH, Rosenbloom AL, Martinez V, et al. Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population. The Journal of Clinical Endocrinology and Metabolism. 1998;83:1953–1958
  40. Cediel R, Riquelme R, Contreras J, et al. Sensorineural hearing loss in insulin-like growth factor I-null mice: a new model of human deafness. European Journal of Neuroscience. 2006;23:587–590
  41. Camarero G, Avendano C, Fernandez-Moreno C, et al. Delayed inner ear maturation and neuronal loss in postnatal Igf-1-deficient mice. The Journal of Neuroscience. 2001;21:7630–7641
  42. Lewitt MS, Scott FP, Clarke NM, et al. Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy. The Journal of Endocrinology. 1998;159:265–274
  43. Ueki I, Ooi GT, Tremblay ML, et al. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:6868–6873
  44. Domene HM, Bengolea SV, Martinez AS, et al. Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. The New England Journal of Medicine. 2004;350:570–577
  45. Hwa V, Haeusler G, Pratt KL, et al. Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure. The Journal of Clinical Endocrinology and Metabolism. 2006;91:1826–1831
  46. van Duyvenvoorde HA, Twickler ThB, Van Doorn J, et al. A novel mutation of the acid-labile subunit (ALS) in two male siblings is associated with persistent short stature, microcephaly and osteoporosis. Submitted for publication.
  47. Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. The New England Journal of Medicine. 2003;349:2211–2222
  48. Raile K, Klammt J, Schneider A, et al. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R. The Journal of Clinical Endocrinology and Metabolism. 2006;91:2264–2271
  49. Walenkamp MJE, Van der Kamp HJ, Pereira AM, et al. A Variable degree of intrauterine and postnatal growth retardation in a family with a missense mutation in the insulin-like growth factor I receptor. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3062–3070
  50. Kawashima Y, Kanzaki S, Yang F, et al. Mutation at cleavage site of insulin-like growth factor receptor in a short-stature child born with intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism. 2005;90:4679–4687
  51. Inagaki K, Tiulpakov A, Rubtsov P, et al. A familial IGF-1 receptor mutant leads to short stature: clinical and biochemical characterization. The Journal of Clinical Endocrinology and Metabolism. 2007;92:1542–1548
  52. Kawashima Y, Yang F, Miura M, et al. A family with short stature born intrauterine growth retardation bearing a new missense mutation at a subunit of IGF-I receptor (R431L). The Endocrine Society's 88th Annual Meeting 2006. 426. [abstract P2-117].
  53. Clapp , Schmidt S, Paranjape A, et al. Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. American Journal of Obstetrics and Gynecology. 2004;190:730–736
  54. Chellakooty M, Vangsgaard K, Larsen T, et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. The Journal of Clinical Endocrinology and Metabolism. 2004;89:384–391
  55. Laviola L, Perrini S, Belsanti G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005;146:1498–1505
  56. Roback EW, Barakat AJ, Dev VG, et al. An infant with deletion of the distal long arm of chromosome 15 (q26.1–qter) and loss of insulin-like growth factor 1 receptor gene. American Journal of Medical Genetics. 1991;38:74–79
  57. Siebler T, Lopaczynski W, Terry CL, et al. Insulin-like growth factor I receptor expression and function in fibroblasts from two patients with deletion of the distal long arm of chromosome 15. The Journal of Clinical Endocrinology and Metabolism. 1995;80:3447–3457
  58. Tonnies H, Schulze I, Hennies HC, et al. De novo terminal deletion of chromosome 15q26.1 characterised by comparative genomic hybridisation and FISH with locus specific probes. Journal of Medical Genetics. 2001;38:617–621
  59. Pinson L, Perrin A, Plouzennec C, et al. Detection of an unexpected subtelomeric 15q26.2 → qter deletion in a little girl: clinical and cytogenetic studies. American Journal of Medical Genetics. Part A. 2005;138:160–165
  60. Bhakta KY, Marlin SJ, Shen JJ, et al. Terminal deletion of chromosome 15q26.1: case report and brief literature review. Journal of Perinatology. 2005;25:429–432
  61. Walenkamp MJE, de Muinck Keizer-Schrama SM, de Mos M, et al. Succesful long-term growth hormone therapy in a girl with haploinsufficiency of the IGF-I receptor due to a terminal 15q26.2 → qter deletion. Journal of Clinical Endocrinology and Metabolism, in press.
  62. Okubo Y, Siddle K, Firth H, et al. Cell proliferation activities on skin fibroblasts from a short child with absence of one copy of the type 1 insulin-like growth factor receptor (IGF1R) gene and a tall child with three copies of the IGF1R gene. The Journal of Clinical Endocrinology and Metabolism. 2003;88:5981–5988
  63. Kant SG, Kriek M, Walenkamp MJ, et al. Tall stature and duplication of the insulin-like growth factor I receptor gene. European Journal of Medical Genetics. 2007;50:1–10
  64. Crossey PA, Pillai CC, Miell JP. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. The Journal of Clinical Investigation. 2002;110:411–418
  65. Holmes R, Montemagno R, Jones J, et al. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Human Development. 1997;49:7–17
  66. Street ME, Seghini P, Fieni S, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. European Journal of Endocrinology. 2006;155:567–574
  67. Osorio M, Torres J, Moya F, et al. Insulin-like growth factors (IGFs) and IGF binding proteins-1, -2, and -3 in newborn serum: relationships to fetoplacental growth at term. Early Human Development. 1996;46:15–26
  68. Tazuke SI, Mazure NM, Sugawara J, et al. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:10188–10193
  69. Kajimura S, Aida K, Duan C. Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:1240–1245
  70. Baumeister FA, Engelsberger I, Schulze A. Pancreatic agenesis as cause for neonatal diabetes mellitus. Klinische Pädiatrie. 2005;217:76–81
  71. Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics. 1998;19:268–270
  72. Weedon MN, Clark VJ, Qian Y, et al. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. American Journal of Human Genetics. 2006;79:991–1001
  73. Taylor SI, Cama A, Accili D, et al. Mutations in the insulin receptor gene. Endocrine Reviews. 1992;13:566–595
  74. Krook A, O'Rahilly S. Mutant insulin receptors in syndromes of insulin resistance. Baillière's Clinical Endocrinology and Metabolism. 1996;10:97–122
  75. Walenkamp MJ, Wit JM. Genetic disorders in the growth hormone–insulin-like growth factor-I axis. Hormone Research. 2006;66:221–230
  76. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Research. 2002;30:e57

PII: S1521-690X(08)00029-8

doi: 10.1016/j.beem.2008.02.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 433-446 , June 2008

Article Tools